Corbus Pharmaceuticals (CRBP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

The heavy selling pressure might have exhausted for Nkarta (NKTX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

'Reference customers loved Akamai's detection capabilities and appreciated how easy it is to automate functionality.' CAMBRIDGE, Mass.

Accenture PLC (NYSE:ACN) and Five Below Inc (NASDAQ:FIVE) stocks are making significant moves following their latest earnings reports.

Candel Therapeutics Inc (NASDAQ:CADL) announced that it has partnered with IDEA Pharma to advance the commercialization of its lead immunotherapy candidate CAN-2409. The collaboration follows positive Phase 3 data showing CAN-2409 significantly improved disease-free survival in patients with intermediate-to-high-risk localized prostate cancer.

The U.S. cannabis industry continues expanding, creating opportunities for ancillary companies that support cultivation and retail operations the U.S. legal cannabis industry experienced significant growth, with sales reaching approximately $31.4 billion, marking a 9.14% increase from the previous year. Industry experts predict sales could reach $50 billion by 2028 as more states legalize marijuana. Recently, Congress discussed federal cannabis reform, increasing speculation about potential rescheduling. If federal legalization advances, ancillary stocks could see strong momentum. These companies provide essential products, including hydroponics, lighting, and packaging, benefiting from growing cannabis demand. As the industry evolves, investors are closely watching top-performing ancillary …

Denali (DNLI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

CVX CEO Mike Wirth lobbies Washington for a 60-day extension to wind down operations in Venezuela after Trump revokes its oil pumping license.

Jabil (JBL) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to earnings of $1.68 per share a year ago.

RNC Chairman Michael Whatley weighs in on President Donald Trump's approval rating and the party preparing for the midterms during a wide-ranging interview on 'Mornings with Maria.'

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELAN.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spire Global, Inc. ("Spire" or "the Company") (NYSE:SPIR). Investors who purchased Spire securities prior to May 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SPIR.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teradata Corporation ("Teradata" or "the Company") (NYSE:TDC). Investors who purchased Teradata securities prior to February 13, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TDC.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SAGE.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methanex Corporation ("Methanex" or "the Company") (NASDAQ:MEOH). Investors who purchased Methanex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MEOH.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprout Social, Inc. ("Sprout" or "the Company") (NASDAQ:SPT). Investors who purchased Sprout securities prior to November 3, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SPT.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EVLV.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. ("Flux" or "the Company") (NASDAQ:FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLUX.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INOD.